AbCellera Biologics Inc (ABCL) Stock: Should Investors Follow These Insider Trades?
AbCellera Biologics Inc (NASDAQ:ABCL) saw a downside of -1.47% to close Tuesday at $4.70 after subtracting -$0.07 on the day. The 5-day average trading volume is 2,162,700 shares of the company’s common stock. It has gained $5.30 in the past week and touched a new high 1 time within the past 5 days. An average […]
Monitor The Insider Activity Of AbCellera Biologics Inc. (ABCL)
As of Wednesday close, AbCellera Biologics Inc.’s (NASDAQ:ABCL) stock traded at $5.08. The average number of shares traded per day over the past five days has been 1,796,060 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.17 fall in that time frame. In the last twenty days, the […]
Is AbCellera Biologics Inc. (ABCL) A Solid Choice On The Value Front?
The stock of AbCellera Biologics Inc. (NASDAQ:ABCL) increased by $0.08 on Wednesday to $5.74, up 1.50 percent. The last five days have seen an average of 1,011,831 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$4.41. The average number of shares traded over the […]
AbCellera Biologics Inc. (ABCL) 10% Owner Owns Stock Worth $0.15 million
AbCellera Biologics Inc. (NASDAQ:ABCL) finished Thursday with a subtraction of -$0.01 to close at $5.49, a downside of -0.22 percent. An average of 1,045,556 shares of common stock have been traded in the last five days. There was a fall of -$0.07 in the past week, and it reached a new high 8 times over […]
Interested In Buying AbCellera Biologics Inc. (ABCL)? Make Sure You Read This First
The stock of AbCellera Biologics Inc. (NASDAQ:ABCL) decreased by -$0.07 on Tuesday to finish at $5.52, down -1.25 percent. The last five days have seen an average of 2,136,360 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$4.61. The average number of shares traded […]
